Stay updated on MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial
Sign up to get notified when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2F25rCGkP8qobiKggV1jn39Q_PcTE.uncropped.jpg&w=3840&q=75)
Latest updates to the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page
- Check3 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.3%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new study on the efficacy and safety of Enlicitide Decanoate (MK-0616) in adults with hypercholesterolemia has been added, while the previous study on MK-0616 has been removed.SummaryDifference2%
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
- Check32 days agoNo Change Detected
- Check46 days agoChange DetectedThe website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.SummaryDifference6%
- Check53 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.3%
- Check67 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision or update to the content of the webpage.SummaryDifference0.3%
Stay in the know with updates to MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.